Trimazosin hydrochloride anhydrous

(R)-(-)-4-Isopropyl-3-propionyl-2-oxazolidinone.

(R)-(-)-4-Isopropyl-3-propionyl-2-oxazolidinone.

A stable analog of adenosine that acts as an agonist for adenosine receptors (Ki = 0.3, 0.

A stable analog of adenosine that acts as an agonist for adenosine receptors (Ki = 0.3, 0.

3-(1H-Pyrazol-4-yl)aniline.

Application 3-(Trimethylsilyl)propynoic acid (3-(Trimethylsilyl)propiolic acid) may be used as starting reagent for the synthesis of 3-trimethylsilylpropynamides. 3-(Trimethylsilyl)propynoic acid may be used in the regioselective preparation of

Application 3-(Trimethylsilyl)propynoic acid (3-(Trimethylsilyl)propiolic acid) may be used as starting reagent for the synthesis of 3-trimethylsilylpropynamides. 3-(Trimethylsilyl)propynoic acid may be used in the regioselective preparation of

3-Formylbenzoic acid is a polar aromatic aldehyde used in the synthesis of 3-hydroxymethylbenzoic acid via reduction. Application 3-Formylbenzoic acid was used in the synthesis of: bicyclic cis -2-azetidinone derivatives via Ugi 4-centre

3-METHYL-2-BENZOTHIAZOLINONE AZINE WITH 4-(2-(ME-ACRYLOYL-O)ETO)-M-ANISALDEHYDE-

A-192621 is a potent, nonpeptide, orally active and selective endothelin B (ETB) receptor antagonist with an IC50 of 4.5 nM and a Ki of 8.8 nM. The selectivity of A-192621 is 636-fold higher than ETA (IC50 of 4280 nM and Ki of 5600 nM). A-192621

A-192621 is a potent, nonpeptide, orally active and selective endothelin B (ETB) receptor antagonist with an IC50 of 4.5 nM and a Ki of 8.8 nM. The selectivity of A-192621 is 636-fold higher than ETA (IC50 of 4280 nM and Ki of 5600 nM). A-192621

A-192621 is a potent, nonpeptide, orally active and selective endothelin B (ETB) receptor antagonist with an IC50 of 4.5 nM and a Ki of 8.8 nM. The selectivity of A-192621 is 636-fold higher than ETA (IC50 of 4280 nM and Ki of 5600 nM). A-192621